Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition-Reference-Cited by-同舟云学术

Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition

Published:2018-07-09 Issue:5 Volume:11 Page:1477-1486
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Schroeder Holly A.,Nunn Kenetta L.,Schaefer Alison,Henry Christine E.,Lam Felix,Pauly Michael H.,Whaley Kevin J.,Zeitlin Larry,Humphrys Mike S.,Ravel Jacques,Lai Samuel K.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41385-018-0054-z.pdf

Reference52 articles.

1. Gipson, I. Mucins of the human endocervix. Front. Biosci. 6, D1245–D1255 (2001).

2. Kieweg S. L. Gravity‐induced coating flows of vaginal gel formulations: In vitro experimental analysis J. Pharmaceut. Sci. 93, 2941–2952 (2014).

3. Nguyen, P. V. Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection. Cell Mol. Immunol. 11, 410–427 (2014).

4. Cone, R. A. Barrier properties of mucus. Adv. Drug Deliv. Rev. 61, 75–85 (2009).

5. Cole, A. Innate host defense of human vaginal and cervical mucosae. Curr. Top. Microbiol Immunol. 306, 199–230 (2006).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Green biotherapeutics: overcoming challenges in plant-based expression platforms;Plant Biotechnology Reports;2024-06-21

2. ZMapp reduces diffusion of Ebola viral particles in fresh human cervicovaginal mucus;Emerging Microbes & Infections;2024-05-16

3. Different Forms of TFF3 in the Human Endocervix, including a Complex with IgG Fc Binding Protein (FCGBP), and Further Aspects of the Cervico-Vaginal Innate Immune Barrier;International Journal of Molecular Sciences;2024-02-14

4. Engineering a “muco‐trapping” ACE2‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID‐19;Bioengineering & Translational Medicine;2024-02-07

5. Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections;Advanced Science;2024-01-15